Terms: = Liver cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
363 results:
1. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β-catenin axis.
Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
[TBL] [Abstract] [Full Text] [Related]
2. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma.
Tang S; Chen H
J Environ Pathol Toxicol Oncol; 2024; 43(3):51-67. PubMed ID: 38608145
[TBL] [Abstract] [Full Text] [Related]
4. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNAFOXD1-AS1 modulated CTCs epithelial-mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR-615-3p.
Guo BL; Zheng QX; Jiang YS; Zhan Y; Huang WJ; Chen ZY
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2050. PubMed ID: 38517478
[TBL] [Abstract] [Full Text] [Related]
6. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
7. Unlocking hepatocellular carcinoma aggression: STAMBPL1-mediated TRAF2 deubiquitination activates WNT/pi3k/NF-kb signaling pathway.
Wang Z; Zhang Y; Shen Y; Zhou H; Gao Y; Zhu C; Qin X
Biol Direct; 2024 Feb; 19(1):18. PubMed ID: 38419066
[TBL] [Abstract] [Full Text] [Related]
8. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/pi3k/Akt pathway.
Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
[TBL] [Abstract] [Full Text] [Related]
9. NDC1 promotes hepatocellular carcinoma tumorigenesis by targeting BCAP31 to activate pi3k/AKT signaling.
Liu YP; Guo G; Ren M; Li YR; Guo D; She JJ; He SX
J Biochem Mol Toxicol; 2024 Feb; 38(2):e23647. PubMed ID: 38348718
[TBL] [Abstract] [Full Text] [Related]
10. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
Lee S; Shin W; Park DG; Namgung H
Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via pi3k/AKT Pathway.
Wang J; Yu Z; Jiang Y; Le T; Wu Y; Li Z; Zhang G; Wu F; Ma H
Front Biosci (Landmark Ed); 2024 Jan; 29(1):35. PubMed ID: 38287824
[TBL] [Abstract] [Full Text] [Related]
12. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract] [Full Text] [Related]
13. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract] [Full Text] [Related]
14. FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1.
Guo C; Zhou N; Lu Y; Mu M; Li Z; Zhang X; Tu L; Du J; Li X; Huang D; Xu Q; Zheng X
Biomed Pharmacother; 2024 Jan; 170():115955. PubMed ID: 38048735
[TBL] [Abstract] [Full Text] [Related]
15. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting EGFR in vitro and in vivo.
Li Q; Niu JQ; Jia JH; Xu W; Bai M; Yao GD; Song SJ
Bioorg Chem; 2024 Feb; 143():107007. PubMed ID: 38039928
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
[TBL] [Abstract] [Full Text] [Related]
17. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration.
Shen W; Yuan L; Cheng F; Wu Z; Li X
Genes Genomics; 2024 Jan; 46(1):49-64. PubMed ID: 37985547
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
19. USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma.
Chen J; Ning D; Du P; Liu Q; Mo J; Liang H; Zhang W; Zhang M; Jiang L; Zhang B; Chen X
Oncogene; 2024 Jan; 43(2):123-135. PubMed ID: 37973952
[TBL] [Abstract] [Full Text] [Related]
20. IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-pi3k/AKT signaling upon CD97 activation.
Meng ZW; Zhang L; Cai XR; Wang X; She FF; Chen YL
Sci Rep; 2023 Oct; 13(1):18711. PubMed ID: 37907543
[TBL] [Abstract] [Full Text] [Related]
[Next]
